TrialInternational wound journal2024

Topical pravibismane as adjunctive therapy for moderate or severe diabetic foot infections: A phase 1b randomized, multicenter, double-blind, placebo-controlled trial.

Benjamin A Lipsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.